Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 15 studies | 29% ± 14% | |
peripheral blood | 11 studies | 32% ± 11% | |
intestine | 10 studies | 24% ± 10% | |
brain | 7 studies | 27% ± 10% | |
liver | 6 studies | 31% ± 19% | |
eye | 5 studies | 20% ± 6% | |
pancreas | 4 studies | 43% ± 16% | |
kidney | 4 studies | 20% ± 2% | |
lymph node | 3 studies | 28% ± 11% | |
breast | 3 studies | 26% ± 5% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 9044.95 | 1445 / 1445 | 100% | 188.06 | 183 / 183 |
liver | 100% | 9580.06 | 226 / 226 | 100% | 130.76 | 406 / 406 |
pancreas | 100% | 5406.43 | 328 / 328 | 100% | 187.36 | 178 / 178 |
prostate | 100% | 8366.73 | 245 / 245 | 100% | 284.67 | 502 / 502 |
breast | 100% | 9052.26 | 459 / 459 | 100% | 147.90 | 1117 / 1118 |
lung | 100% | 7336.09 | 577 / 578 | 100% | 155.45 | 1155 / 1155 |
brain | 100% | 5504.22 | 2635 / 2642 | 100% | 98.41 | 705 / 705 |
bladder | 100% | 8384.00 | 21 / 21 | 100% | 147.56 | 502 / 504 |
intestine | 100% | 8329.37 | 966 / 966 | 99% | 209.57 | 524 / 527 |
thymus | 100% | 7924.34 | 653 / 653 | 99% | 134.19 | 601 / 605 |
stomach | 100% | 6001.23 | 359 / 359 | 99% | 205.19 | 283 / 286 |
uterus | 100% | 4736.81 | 170 / 170 | 99% | 138.94 | 454 / 459 |
ovary | 100% | 4051.27 | 180 / 180 | 99% | 70.37 | 425 / 430 |
kidney | 100% | 5758.97 | 89 / 89 | 97% | 105.36 | 878 / 901 |
skin | 100% | 7363.55 | 1808 / 1809 | 94% | 93.56 | 446 / 472 |
adrenal gland | 100% | 4536.00 | 257 / 258 | 88% | 50.51 | 203 / 230 |
adipose | 100% | 10054.15 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 12090.84 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 100.88 | 29 / 29 |
muscle | 100% | 5743.43 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 4787.36 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 132.20 | 45 / 45 |
heart | 97% | 4467.28 | 834 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 76% | 52.24 | 61 / 80 |
peripheral blood | 59% | 3556.95 | 545 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0046705 | Biological process | CDP biosynthetic process |
GO_0006222 | Biological process | UMP biosynthetic process |
GO_0006207 | Biological process | 'de novo' pyrimidine nucleobase biosynthetic process |
GO_0046940 | Biological process | nucleoside monophosphate phosphorylation |
GO_0015949 | Biological process | nucleobase-containing small molecule interconversion |
GO_0006225 | Biological process | UDP biosynthetic process |
GO_0009220 | Biological process | pyrimidine ribonucleotide biosynthetic process |
GO_0005730 | Cellular component | nucleolus |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0033862 | Molecular function | UMP kinase activity |
GO_0004550 | Molecular function | nucleoside diphosphate kinase activity |
GO_0036431 | Molecular function | dCMP kinase activity |
GO_0004849 | Molecular function | uridine kinase activity |
GO_0036430 | Molecular function | CMP kinase activity |
GO_0005524 | Molecular function | ATP binding |
GO_0004127 | Molecular function | (d)CMP kinase activity |
GO_0050145 | Molecular function | nucleoside monophosphate kinase activity |
Gene name | CMPK1 |
Protein name | Cytidine/uridine monophosphate kinase 1 UMP-CMP kinase (EC 2.7.4.14) (Deoxycytidylate kinase) (CK) (dCMP kinase) (Nucleoside-diphosphate kinase) (EC 2.7.4.6) (Uridine monophosphate/cytidine monophosphate kinase) (UMP/CMP kinase) (UMP/CMPK) nucleoside-diphosphate kinase (EC 2.7.4.6) |
Synonyms | CMPK CMK UMPK UMK UCK |
Description | FUNCTION: Catalyzes the phosphorylation of pyrimidine nucleoside monophosphates at the expense of ATP. Plays an important role in de novo pyrimidine nucleotide biosynthesis. Has preference for UMP and CMP as phosphate acceptors. Also displays broad nucleoside diphosphate kinase activity. . FUNCTION: Catalyzes the phosphorylation of pyrimidine nucleoside monophosphates at the expense of ATP. Plays an important role in de novo pyrimidine nucleotide biosynthesis. Has preference for UMP and CMP as phosphate acceptors. Also displays broad nucleoside diphosphate kinase activity. . |
Accessions | ENST00000471289.2 ENST00000371873.10 [P30085-3] A0A494BXC7 ENST00000450808.2 ENST00000699075.1 [P30085-1] ENST00000699074.1 E9PJD2 P30085 Q5T0D2 ENST00000371871.8 A0A8V8TMN5 |